The Asia Pacific Antibiotics Market would witness market growth of 6.6% CAGR during the forecast period (2020-2026). The antibacterial agent is another name of antibiotics that has the capability to kill or slow down bacterial growth. It is widely used for curing and preventing diseases caused by bacteria. The increasing number of patients who are suffering from infectious diseases and the evolution of the latest diagnostic devices are some of the major factors that drive the market.
The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases. Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market. On the other hand, advanced prospect molecules and the development of novel combination therapies to cure antibiotic-resistant microbial infections are estimated to propel the market and provide great opportunities for the market players.
With the increasing incidents of infectious diseases, many companies in the market are actively taking efforts for the innovation of advanced products that will propel the growth of the market. There are many infections that become resistant to antibiotics; this situation provides an opportunity for companies to develop advanced products. These advanced products increase the range of treatment by the antibiotics that further support the growth of the market. The innovation of advanced prospect molecules and development of some novel combination therapies which cure antibiotic-resistant infections are expected to support the market growth.
Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Antibiotics Market in Asia Pacific is expected to register a CAGR of 6.6% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.
Scope of the Study
Market Segments Covered in the Report:
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors,
- Mycolic Acid Inhibitors
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides,
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Johnson and Johnson
- Merck & Co., Inc.
- Pfizer, Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A.
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Eli Lilly and Company
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antibiotics Market, by Action Mechanism
1.4.2 Asia Pacific Antibiotics Market, by Drug Class
1.4.3 Asia Pacific Antibiotics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players
Chapter 4. Asia Pacific Antibiotics Market by Action Mechanism
4.1 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country
4.2 Asia Pacific Protein Synthesis Inhibitors Market by Country
4.3 Asia Pacific DNA Synthesis Inhibitors Market by Country
4.4 Asia Pacific RNA Synthesis Inhibitors Market by Country
4.5 Asia Pacific Mycolic Acid Inhibitors Market by Country
Chapter 5. Asia Pacific Antibiotics Market by Drug Class
5.1 Asia Pacific Cephalosporin Market by Country
5.2 Asia Pacific Penicillin Market by Country
5.3 Asia Pacific Fluoroquinolone Market by Country
5.4 Asia Pacific Macrolides Market by Country
5.5 Asia Pacific Carbapenem Market by Country
5.6 Asia Pacific Aminoglycosides Market by Country
5.7 Asia Pacific Sulfonamides Market by Country
5.8 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Antibiotics Market by Country
6.1 China Antibiotics Market
6.1.1 China Antibiotics Market by Action Mechanism
6.1.2 China Antibiotics Market by Drug Class
6.2 Japan Antibiotics Market
6.2.1 Japan Antibiotics Market by Action Mechanism
6.2.2 Japan Antibiotics Market by Drug Class
6.3 India Antibiotics Market
6.3.1 India Antibiotics Market by Action Mechanism
6.3.2 India Antibiotics Market by Drug Class
6.4 South Korea Antibiotics Market
6.4.1 South Korea Antibiotics Market by Action Mechanism
6.4.2 South Korea Antibiotics Market by Drug Class
6.5 Singapore Antibiotics Market
6.5.1 Singapore Antibiotics Market by Action Mechanism
6.5.2 Singapore Antibiotics Market by Drug Class
6.6 Malaysia Antibiotics Market
6.6.1 Malaysia Antibiotics Market by Action Mechanism
6.6.2 Malaysia Antibiotics Market by Drug Class
6.7 Rest of Asia Pacific Antibiotics Market
6.7.1 Rest of Asia Pacific Antibiotics Market by Action Mechanism
6.7.2 Rest of Asia Pacific Antibiotics Market by Drug Class
Chapter 7. Company Profiles
7.1 GlaxoSmithKline PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Product Launches and Product Expansions:
7.3.1.2 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent strategies and developments:
7.4.4.1 Acquisition and Mergers:
7.4.4.2 Product Launches and Product Expansions:
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Novartis AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.5.2 Partnerships, Collaborations, and Agreements:
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Eli Lilly and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 Asia Pacific Antibiotics Market, 2016 - 2019, USD Million
TABLE 2 Asia Pacific Antibiotics Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibiotics Market
TABLE 4 Product Launches And Product Expansions– Antibiotics Market
TABLE 5 Approvals– Antibiotics Market
TABLE 6 Acquisition and Mergers– Antibiotics Market
TABLE 7 Asia Pacific Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 8 Asia Pacific Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 9 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 10 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 11 Asia Pacific Protein Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 12 Asia Pacific Protein Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 13 Asia Pacific DNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 14 Asia Pacific DNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 15 Asia Pacific RNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 16 Asia Pacific RNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 17 Asia Pacific Mycolic Acid Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 18 Asia Pacific Mycolic Acid Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 19 Asia Pacific Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 20 Asia Pacific Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 21 Asia Pacific Cephalosporin Market by Country, 2016 - 2019, USD Million
TABLE 22 Asia Pacific Cephalosporin Market by Country, 2020 - 2026, USD Million
TABLE 23 Asia Pacific Penicillin Market by Country, 2016 - 2019, USD Million
TABLE 24 Asia Pacific Penicillin Market by Country, 2020 - 2026, USD Million
TABLE 25 Asia Pacific Fluoroquinolone Market by Country, 2016 - 2019, USD Million
TABLE 26 Asia Pacific Fluoroquinolone Market by Country, 2020 - 2026, USD Million
TABLE 27 Asia Pacific Macrolides Market by Country, 2016 - 2019, USD Million
TABLE 28 Asia Pacific Macrolides Market by Country, 2020 - 2026, USD Million
TABLE 29 Asia Pacific Carbapenem Market by Country, 2016 - 2019, USD Million
TABLE 30 Asia Pacific Carbapenem Market by Country, 2020 - 2026, USD Million
TABLE 31 Asia Pacific Aminoglycosides Market by Country, 2016 - 2019, USD Million
TABLE 32 Asia Pacific Aminoglycosides Market by Country, 2020 - 2026, USD Million
TABLE 33 Asia Pacific Sulfonamides Market by Country, 2016 - 2019, USD Million
TABLE 34 Asia Pacific Sulfonamides Market by Country, 2020 - 2026, USD Million
TABLE 35 Asia Pacific Others Market by Country, 2016 - 2019, USD Million
TABLE 36 Asia Pacific Others Market by Country, 2020 - 2026, USD Million
TABLE 37 Asia Pacific Antibiotics Market by Country, 2016 - 2019, USD Million
TABLE 38 Asia Pacific Antibiotics Market by Country, 2020 - 2026, USD Million
TABLE 39 China Antibiotics Market, 2016 - 2019, USD Million
TABLE 40 China Antibiotics Market, 2020 - 2026, USD Million
TABLE 41 China Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 42 China Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 43 China Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 44 China Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 45 Japan Antibiotics Market, 2016 - 2019, USD Million
TABLE 46 Japan Antibiotics Market, 2020 - 2026, USD Million
TABLE 47 Japan Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 48 Japan Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 49 Japan Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 50 Japan Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 51 India Antibiotics Market, 2016 - 2019, USD Million
TABLE 52 India Antibiotics Market, 2020 - 2026, USD Million
TABLE 53 India Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 54 India Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 55 India Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 56 India Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 57 South Korea Antibiotics Market, 2016 - 2019, USD Million
TABLE 58 South Korea Antibiotics Market, 2020 - 2026, USD Million
TABLE 59 South Korea Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 60 South Korea Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 61 South Korea Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 62 South Korea Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 63 Singapore Antibiotics Market, 2016 - 2019, USD Million
TABLE 64 Singapore Antibiotics Market, 2020 - 2026, USD Million
TABLE 65 Singapore Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 66 Singapore Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 67 Singapore Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 68 Singapore Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 69 Malaysia Antibiotics Market, 2016 - 2019, USD Million
TABLE 70 Malaysia Antibiotics Market, 2020 - 2026, USD Million
TABLE 71 Malaysia Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 72 Malaysia Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 73 Malaysia Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 74 Malaysia Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 75 Rest of Asia Pacific Antibiotics Market, 2016 - 2019, USD Million
TABLE 76 Rest of Asia Pacific Antibiotics Market, 2020 - 2026, USD Million
TABLE 77 Rest of Asia Pacific Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 78 Rest of Asia Pacific Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 79 Rest of Asia Pacific Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 80 Rest of Asia Pacific Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 81 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 82 Key information –Johnson and Johnson
TABLE 83 key information - Merck & Co., Inc.
TABLE 84 Key Information – Pfizer, Inc.
TABLE 85 Key Information – Bayer AG
TABLE 86 Key Information – Novartis AG
TABLE 87 Key Information – Sanofi S.A.
TABLE 88 Key Information – Abbott Laboratories
TABLE 89 key information – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Eli Lilly and Company
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players
FIG 5 Recent strategies and developments: Merck & Co., Inc.
FIG 6 Recent strategies and developments: Pfizer, Inc.
FIG 7 Recent strategies and developments: Sanofi S.A.